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Abstract
Background: Several studies in both humans and rodents have examined the use of lactoferrin as a dietary
solution to weight gain and visceral fat accretion and have shown promising results in the short term (up to
7 weeks). This study examined the effects of giving lactoferrin over a longer period of time.
Methods: For 13 weeks, male C57/BL6J mice were given a diet containing 10 % kJ fat and 20 % kJ casein (LFD) or
a diet with 45 % kJ fat and either 20 % kJ casein (HFD) or 20 % kJ lactoferrin (HFD + Lac). Physiological, metabolic,
and biochemical parameters were investigated. Gene expression was investigated by Real-Time PCR and microarray.
All data was assessed using t-test, ANOVA or ANCOVA. Gene Set Enrichment Analysis was used to interpret
microarray data and assess the impact on gene sets with common biological roles.
Results: By the end of the trial, HFD + Lac fed mice did not alter energy balance, body composition, bodyweight,
or weight gain when compared to the HFD group. Notably, there were no changes in subcutaneous or epididymal
adipose leptin mRNA levels between high fat diet groups, however plasma leptin was significantly reduced in the
HFD + Lac compared to HFD group (P < 0.05) suggesting reduced leptin secretion. Global microarray analysis of the
hypothalamus indicate an overall reduction in gene sets associated with feeding behaviour (P < 0.01) and an up-
regulation of gene sets associated with retinol metabolism in the HFD + Lac group compared to the HFD group
(P < 0.01). Genes in the latter catergory have been shown to impact on the hypothalamic-pituitary-adrenal axis.
Notably, plasma corticosterone levels in the HFD + Lac group were reduced compared to the HFD fed mice (P < 0.05).
Conclusions: The data suggests that prolonged feeding of full-length dietary lactoferrin, as part of a high fat diet, does
not have a beneficial impact on weight gain when compared to casein. However, its impact on leptin secretion and
accompanying changes in hypothalamic gene expression may underlie how this dietary protein alters plasma
corticosterone. The lactoferrin fed mouse model could be used to identify leptin and corticosterone regulated genes in
the hypothalamus without the confounding effects of body weight change.
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Background
The number of people who can be classified as over-
weight (body mass index = 25–29.9 kg/m2) or obese
(body mass index ≥ 30 kg/ m2) is expected to rise to in-
clude as much as 75 % of the population in the United
States and up to 70 % in the UK by the year 2020 [1].
Health implications associated with obesity, such as cer-
tain types of cancer, cardiovascular disease, diabetes mel-
litus type 2, and non-alcoholic fatty liver disease, reduce
life expectancy and quality of life and at the same time
increase the medical costs required to care for those
afflicted with such diseases [1]. As increases in obesity
have such an impact on the individual and society as a
whole, greater research into dietary solutions for obesity
has been undertaken in recent years.
One such dietary solution is focused on the use of
whey protein isolate (WPI), which has been shown to re-
duce weight gain associated with the intake of high fat
diets [2, 3]. Tranberg et al. showed that the beneficial
impact WPI has on weight gain in high fat diet fed ado-
lescent mice took place primarily during the initial four
weeks of WPI intervention when mice were 5 to 9 weeks
old [3]. Following this time point, high fat diet-induced
weight gain is re-established, however, final body weight
reductions are still significant due to the early effects of
WPI intervention on weight gain [3]. Previously, we
found that bovine serum albumin (BSA), a constituent
protein of WPI, had a significant impact on weight gain
in mice when diet intervention was started at a later
stage in adolescence than those in the Tranberg et al.
study [4]. In our BSA study, 8 week old male mice were
provided with high fat diets containing either casein or
BSA as the dominant source of protein [4]. After
13 weeks of high fat diet feeding, BSA fed mice had sig-
nificantly reduced body weight compared to the casein
control, similar to the WPI fed mice in the Tranberg et
al. study [3, 4]. In contrast to the Tranberg et al. study,
BSA fed mice reduced weight gain from 8 to 16 weeks
of age during the transition from adolescence to adult-
hood, which suggests an impact of BSA on weight gain
for a lengthier period of time and across a broader age
range than WPI [4].
Lactoferrin, a glycoprotein found in whey, has been
shown to have beneficial effects in the management
obesity over multiple age categories [5]. For instance, in
comparison to mice given casein, mice given bovine
lactoferrin as a supplement to casein (15 % bovine lacto-
ferrin: 85 % casein) have been shown to increase weight
loss on a 70 %-reduced calorie-restricted diet for 50 days
and impede weight regain when given ad libitum access
to food over the course of another 50 days [5]. Similarly,
gastric intubation of bovine lactoferrin in 8-week old
ICR mice fed a standard diet for 4 weeks resulted in re-
duced visceral adipose mass and hepatic triacylglycerol
(TAG) accumulation [6]. In a different trial carried out
by Takeuchi et al., ICR mice fed a standard chow diet
and supplemented with bovine lactoferrin over 4 weeks
had significantly reduced plasma non-esterified fatty
acids (NEFA), TAG, and increased high-density lipopro-
tein cholesterol; however, mice fed a high fat diet and
supplemented with bovine lactoferrin showed no change
in these lipid metabolites compared to the control high
fat diet [7]. Likewise, Sprague–Dawley rats fed a high fat
diet with gastric intubation of bovine lactoferrin did not
have any observed beneficial impact compared to con-
trols [6]. In light of the inconsistent results, further work
is required to understand the effects of bovine lactofer-
rin on weight gain when given alongside a high fat diet
over a prolong period of time.
To this end, male C57BL/6 J mice were provided with
high fat diets containing either casein or bovine lactofer-
rin at 8 weeks of age, which corresponded with our BSA
study as well as the Morishita et al. study [4, 6]. Diets
continued for 13 weeks, in line with our BSA trial, to
examine the impact of bovine lactoferrin on energy bal-
ance over a longer duration during the growth period
between adolescence to fully mature adult mice. As part
of this study, we undertook a microarray approach to as-
sess the impact of lactoferrin on the hypothalamic gene
expression important for energy balance regulation and
subjected the data to a powerful analytical method called
Gene Set Enrichment Analysis (GSEA), as detailed by
Subramanian et al. [8]. Rather than focusing on individ-
ual genes, GSEA approach assesses if gene sets with
common biological roles or regulation are affected by
the intervention of interest. This provides a more mean-
ingful answer to how an intervention affected physio-
logical processes by focusing on pathways rather than
individual genes and gave greater insight into how lacto-
ferrin affects key energy balance related parameters in
HFD fed mice.
Methods
Animals and diets
The animals in this experiment were maintained in ac-
cordance with a license obtained under the Cruelty to
Animals Act 1876, and all work adhered with University
College Cork Animal Ethics Committee approval
(#2011/005). Male C57/BL6J mice, aged 3–4 weeks
(Harlan, Middlesex, UK), were weight matched (17.89 ±
1.68 g) and randomly group housed (4 per cage, 8 per
group) in individually ventilated cages. The environment
animals were kept in was 20–22 °C, 45–65 % humidity,
and in 12:12 h light–dark cycles. Mice had ad libitum
access to fresh water and one of three diets (Research
Diets, New Brunswick, USA): LFD (low fat diet; 10 % en-
ergy fat and 20 % energy casein; D12450B), HFD (high
fat diet with casein; 45 % energy fat and 20 % energy
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casein; D12451), or HFD + Lac (high fat diet with bovine
lactoferrin; D12451 with 20 % energy bovine lactoferrin;
Glanbia, Carlsbad, USA), throughout the study. Details
on the diets are in Additional file 1: Table S1.
Experimental protocol
During the 5-week acclimatization period, mice were
allowed ad libitum access to the same LFD and fresh
water. Subsequent to acclimatization, mice were weight
matched and provided with one of 3 diets: LFD, HFD, or
HFD + Lac (N = 8). Weekly bodyweight and food intake
measurements were recorded. To measure metabolic pa-
rameters, mice were housed individually for 72 h in TSE
PhenoMaster system cages (TSE systems, Bad Homburg,
DE) during weeks 9–11 before returning to their home
cages. In week 13, immediately prior to termination, body
composition was determined using a Bruker Minispec
LF50H (Bruker Optics, Stillorgan, EI). Mice were fasted
for 4–6 h, anesthetized (65 mg/kg ketamine and 13 mg/kg
xylazine), and blood was collected into vacutainer EDTA
tubes (Becton, Dickinson and Company, Dublin, EI).
Upon collection, blood was mixed with 500,000 KUI/L
Aprotinin (Sigma-Aldrich, Cambridge, UK) and 0.1 mM
Diprotin A (Sigma-Aldrich, Cambridge, UK). Cervical dis-
location was used to euthanize mice, and tissues were har-
vested, weighed, and snap frozen in dry ice (brain) or
liquid nitrogen before being stored at −80 °C.
Metabolic parameters
The TSE Phenomaster system, comprised of 8 test cages
and 1 reference cage, were calibrated such that feeding
sensors measured food consumption above 0.01 g, and
collected data every 13 min (1.5 min per cage) over the
final 24 h of the 72 h housing period. Indirect open-
circuit calorimetry was used to measure carbon dioxide
(VCO2) production and oxygen (VO2) consumption, and
the respiratory exchange ratio (RER = VCO2/VO2) was
calculated using this data. The sensor and time record-
ing procedures follow those set forth by McAllan, et al.
except that locomotor activity included the Z-axis in
addition to the X and Y axes [2, 9].
Gene expression
Two approaches were used; Real-Time (RT)-PCR and
microarray. The RNA extraction and RT-PCR protocols,
including product and approach, followed protocols set
forth by McAllan et al. [2]. A geometric mean was deter-
mined in instances where two or more housekeeping
genes were used for normalization [10]. Reference genes
included: tyrosine 3-monooxygenase/tryptophan 5-
monooxygenase activation protein, zeta polypeptide
(Ywhaz) and β-actin (Actb) in the jejunum, 18S riboso-
mal 1 (Rna18s) and Actb in adipose tissue, and Rna18s
and Ywhaz in the hypothalamus [2, 9, 11]. The Pfaffl
method was used to determine gene expression relative
to LFD controls [12]. Primer sequences can be found in
Additional file 2: Table S2.
The hypothalamic gene expression was also investi-
gated using the microarray approach in mice from the
HFD and HFD + Lac groups (N = 3). RNA quality was
established on an Agilent Bioanalyzer 2100 using the
2100 expert Eukaryote Total RNA Nano series II soft-
ware (Agilent Technologies, Espoo, FI). Once quality
and concentration were determined, 200 ng of RNA was
converted to cDNA using AffinityScript RNase Block
and labelled according to manufacturer’s instructions
(Agilent Technologies, Espoo, FI). Amplified and la-
belled samples were then purified in Qiagen RNA mini
tube columns (Qiagen, Helsinki, FI) and the success of
labelling was determined using an RNA Spike-In Kit per
manufacturer’s protocol (Exiqon, Vedbaek, DK). Samples
were then mixed with blocking agent, hybridization and
fragmentation buffer, and hybridized to Agilent Sure-
Print G3 Mouse GE 8 × 60 K microarrays at 65 °C for
17 h before they were washed and scanned using an
Agilent Scanner G2505C as set out in the manufacturer’s
directions (Agilent Technologies, Espoo, FI).
Western blot
All procedures pertaining to protein extraction from adi-
pose tissue, SDS-PAGE, Western blotting, and blocking
were performed according to previously defined
methods with some modifications [2]. Specifically, mem-
branes were incubated overnight at 4 °C with the pri-
mary antibody against peroxisome proliferator-activated
receptor alpha (PPARA) (1:500, H-98 SC-9000, Santa
Cruz Biotechnology, Dublin, EI) and against ccaat-
enhancer binding protein alpha (CEBPA) (1:500, 14AA
SC-61, Santa Cruz Biotechnology, Dublin, EI). HRP-
conjugated donkey anti-rabbit secondary antibodies
(1:7500 dilution; 711-035-152, Jackson Immuoresearch,
Newmarket, UK) were incubated at room temperature
for 60 min. Membranes were stained with a 1:15000
dilution of a β-actin-HRP antibody (A3854, Sigma-
Aldrich, Cambridge, UK) to correct for sample loading.
ECL Western blotting Substrate Kit (Thermo Scientific,
Dublin, EI) was used for visualization.
Plasma metabolites and hormones
Commercially available ELISA or calorimetric kits were
used to measure corticosterone, leptin, insulin, glucose,
and TAG levels (Corticosterone: Enzo Life Sciences,
Exeter, UK; leptin and insulin: Alpha Diagnostics,
Eastleigh, UK; glucose: Abcam, Cambridge, UK; TAG:
Wako, Cambridge, USA). Insulin sensitivity in each
group was determined by calculating QUICKI from data
collected from plasma samples (1/(log [insulin (μU/L)] +
log [glucose (mg/dL])) [13].
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To measure plasma amino acid levels in the high fat
diet groups, samples were deproteinated with 24 % (w/v)
trichloroacetic acid at a ratio of 1:1, incubated for
10 min at room temperature, and centrifuged at
14400 rpm (Microcentaur, MSE, UK) for 10 min. Next,
the supernatant was diluted with the internal standard
norleucine, and the quantification of amino acids was
completed using a Joel JLC-500/V amino acid analyzer
(Joel Ltd., Garden City, Herts, UK) fitted with a Joel Na+
high performance cation exchange column.
Fecal fat analysis
A modified version of the Folch method was used to de-
termine % fecal fat [14, 15]. First, pellets were thawed,
distilled water was added (10 mL to 1 g), and they were
allowed to rest at room temperature overnight. Next,
chloroform-methanol (2:1 v/v) and 0.58 % (
w/v) aqueous
NaCl solutions were mixed with samples using a vortex
prior to centrifugation. Then the chloroform phase was
measured and transferred to pre-weighed tubes before
evaporation. Finally, the tubes were re-weighed to deter-
mine total lipid content in the fecal mass. All analyses
were carried out in duplicate.
Statistics
Statistical analyses were completed with the aid of Prism
(GraphPad Software, Inc., La Jolla, USA) and Minitab
(Minitab Inc., Coventry, UK). ANOVA with a Tukey post
hoc test was used to compare 3 groups in all analyses of re-
sults except oxygen consumption (VO2) where an
ANCOVA (SAS software version 9.3, Cary, USA) with total
body weight as the co-variant was used. To analyze West-
ern blot data, non-parametric multiple comparisons
Kruskal-Wallis test followed by, where appropriate, Mann–
Whitney U tests for individual comparisons were used. The
significance of results was established at P < 0.05 and re-
ported as mean ± SEM.
For the microarray analysis, background was corrected
with the normexp method, normalized, and log 2-
tranformed before differences between high fat diet
groups were determined using Bayes moderated t-
statistics. Gene set enrichment analysis of the microarray
data compared significant similarities between differen-
tial expression of HFD and HFD + Lac groups against
known gene sets in the Molecular Signatures Database
Version 5.0 (MSigDB), and normalized data was run
through the GSEA.
Results
Dietary bovine lactoferrin did not alter weight gain or
body composition but did reduce fecal fat excretion
compared to casein
Initially, there was a 4 week delay in achieving a signifi-
cant bodyweight increase in HFD + Lac fed mice
compared to the LFD not seen in the HFD group, which
was significantly increased in week 1 (Fig. 1a). Likewise,
while the HFD group achieved a significant increase in
weight gain compared to the LFD group by week 2, the
HFD + Lac group did not reach a significant increase in
weight gain over the LFD group until week 8 (Fig. 1b).
By the end of the 13 week trial, both high fat diet groups
were significantly greater in % fat mass and reduced in
% lean mass in comparison to the LFD controls (Fig. 1c).
In support of body fat mass percentages, SAT and EAT
fat pads collected from the HFD and HFD + Lac groups
had similar masses and were both significantly greater
than in the LFD group (Table 1). Analysis of metabolic
cage data collected during weeks 9–12 indicated no
changes in EI between groups (Table 1); however, cumu-
lative EI over the length of the study was greater in both
high fat diet groups when compared to the LFD mice
(Fig. 1d). When using bodyweight as a co-variant, a
trend toward decrease in VO2 was noted in the HFD +
Lac group compared to the LFD group (P = 0.08)
(Table 1). The respiratory exchange ratio, consistent with
fat as a primary fuel source, was significantly reduced in
both high fat diet fed groups compared to the LFD
(Table 1), and there was no change in locomotor activity
between all three groups (Table 1).
Regarding hypothalamic mRNA levels of genes associ-
ated with the regulation of EI and energy expenditure,
pro-opiomelanocortin (Pomc) was significantly decreased
in the HFD + Lac group when compared to the LFD
group (Fig. 2a), however, neither neuropeptide Y (Npy)
nor leptin receptor (Ob-r) were significantly altered be-
tween groups (Fig. 2b-c). Interestingly, when microarray
analysis of a gene-set associated with leptin and feeding
behavior was analyzed, there was a significant decrease
in this gene set in the HFD + Lac group compared to the
HFD group (Table 2).
Lipid excretion was examined in fecal samples and
found to be significantly less in the LFD and HFD + Lac
groups when compared to the HFD control group
(Fig. 3a), which is curious given the inherent difference
in fat content between the low fat and high fat diets. To
explore this result further, jejunal mRNA levels associ-
ated with fatty acid transporter (FAT/Cd36), were exam-
ined, and it was found that they were significantly
increased in the HFD + Lac group compared to the LFD
mice (P < 0.05) and also showed an increased trend com-
pared to the HFD group (Fig. 3b).
Plasma leptin and corticosterone were significantly
reduced in mice fed dietary bovine lactoferrin compared
to casein in a high fat diet
Despite similar % fat mass to the HFD group, HFD + Lac
fed mice had significantly reduced circulating leptin con-
centrations (Fig. 4a). Likewise, plasma corticosterone
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Table 1 Metabolic parameter assessments over 24 h for mice fed for 13 weeks with either a 10 % kJ low fat diet with 20 % casein
(LFD), 40 % kJ fat diet with 20 % casein (HFD), or 40 % kJ fat diet 20 % lactoferrin (Lac)
LFD HFD Lac
Energy Intake (kJ) 35.37 ± 2.94 41.11 ± 3.91 50.18 ± 5.25
VO2 (ml/min) 1.81 ± 0.03 1.78 ± 0.03 1.71 ± 0.03
Locomotor Activity (Beam breaks) 229.79 ± 9.75 200.12 ± 12.47 196.35 ± 18.90
RER 0.82 ± 0.02a 0.75 ± 0.01b 0.76 ± 0.01b
Insulin (pmol/L) 5.62 ± 0.10 6.74 ± 0.26 6.61 ± 0.59
Glucose (mmol/L) 10.00 ± 0.62 12.01 ± 1.09 11.01 ± 0.99
QUICKI 0.46 ± 0.01 0.44 ± 0.01 0.45 ± 0.00
FFA (nmol/mL) 0.19 ± 0.04 0.46 ± 0.04 0.36 ± 0.07
SAT mass (g) 0.30 ± 0.02 0.95 ± 0.12 0.77 ± 0.10
EAT mass (g) 0.83 ± 0.10 1.65 ± 0.14 1.79 ± 0.26
All data is represented as mean ± SEM (N = 8). Dissimilar letters represent significance (P < 0.05)
Fig. 1 Effect of dietary bovine lactoferrin on (a) bodyweight, (b) weight gain, (c) body composition, over a 13 week period, and (d) cumulative
energy intake (kJ) through week 8 in C57/BL6 mice. Data represent mean values ± SEM (n = 8). Different letters indicate a significant difference
P < 0.05. Abbreviations: LFD, 10 % energy fat diet with 20 % energy casein; HFD, 45 % energy fat diet with 20 % energy casein; HFD + Lac, 45 %
energy fat diet with 20 % energy lactoferrin
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levels were significantly less in the bovine lactoferrin
group than in the HFD group (Fig. 4b). In the hypothal-
amus, mRNA expression of genes associated with central
control of corticosterone production, namely cortico-
tropin releasing hormone (Crh) and arginine vasopressin
receptor 1a (V1a) did not change between groups
(Fig. 2d-e), however the Kegg Retinol Metabolism path-
way showed a significant increase in the HFD + Lac
group compared to the HFD fed mice (Table 2).
To ascertain an underlying mechanism for how the
plasma leptin changes in lactoferrin fed mice, we
compared the plasma amino acid concentrations in
high fat diet groups and found that mice fed lactofer-
rin had significantly reduced histidine (P < 0.01) and
glutamate (P < 0.01) and increased glycine (P < 0.05)
and isoleucine (P < 0.05) concentrations while other
amino acids remained unchanged between groups
(Table 3). Plasma insulin concentrations were signifi-
cantly greater in both high fat diet fed groups com-
pared to the LFD mice (Fig. 4c), however, there were
no significant changes in plasma glucose or QUICKI
levels (Table 1). It is worth mentioning that plasma
TAG concentrations were significantly increased in
the HFD + Lac group compared to the LFD group,
but no such increase was observed in the HFD group
(Table 1).
Dietary bovine lactoferrin moderately affected adipose
gene expression
Given the reduction of plasma leptin concentrations in
the HFD + Lac mice compared to the HFD group, leptin
(Lep) mRNA levels were compared in adipose tissue
samples. There were no significant changes between
high fat diet fed mice beyond the significant increase
found in both high fat diet fed groups compared to the
LFD group (P < 0.05) (LFD: 1.00 ± 0.11; HFD: 3.29 ± 0.44;
HFD + Lac: 3.69 ± 0.55).
To determine whether there were differences in
mRNA levels of genes associated with the mechanisms
surrounding lipid accretion given the reduced fat excre-
tion in lactoferrin fed mice, we first examined CCAAT-
enhancer-binding protein a (Cebpa), a gene associated
with adipogenesis, and found a significant decrease in
mRNA levels in the HFD + Lac and HFD group
Fig. 2 Effect of dietary bovine lactoferrin on hypothalamic gene expression of pro-opiomelanocortin (Pomc) (a), neuropeptide Y (Npy) (b), leptin
receptor (Obr) (c), corticotropin releasing hormone (Crh) (d), and arginine vasopressin receptor 1a (V1a) (e). Data is represented as mean values ±
SEM (n = 8). Different letters indicate significant differences, and significance is determined at P < 0.05. Abbreviations: LFD, 10 % energy fat diet
with 20 % energy casein; HFD, 45 % energy fat diet with 20 % energy casein; HFD + Lac, 45 % energy fat diet with 20 % energy lactoferrin
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compared to the LFD mice (Additional file 3: Figure S1A).
However protein expression of CEBPA p42 between
groups was not altered (Additional file 4: Figure S2B).
While no differences were found between high fat diet fed
groups in the mRNA levels of β-oxidation related Ppara
(Additional file 3: Figure S1B), western blot analysis indi-
cated that SAT PPARA was significantly reduced in the
HFD + Lac group compared to the LFD group, but not in
the HFD group (Additional file 4: Figure S2A). No SAT al-
terations were found between the high-fat fed groups for
genes associated with lipid uptake, specifically, lipoprotein
lipase (Lpl), or genes associated with lipid catabolism
namely, carnitine palmitoyltransferase 1b (Cpt1b) and
beta-adrenergic receptor-3 (b3ar) (Additional file 3: Figure
S1C-D). There was not a significant difference between
high fat diet fed groups in mRNA level of peroxisome
proliferator-activated receptor-gamma (Pparg), a gene
associated with adipogenesis, nor was there a difference
Table 2 Hypothalamic gene-set analysis comparing the HFD
and HFD + Lac groupsa
Name Systematic
name
NES NOM p-value FDR q-value
Feeding behavior M17480 −1.7317742 P < 0.01 0.09125667
Agrp
Brs3
Cartpt
Cckar
Cckbr
Fyn
Galr2
Glg
Ghr1
Ghsr
Hctrl
Mc4r
Pmch
Pyy
Ubr3
Kegg retinol
metabolism
M9488 1.8021116 P < 0.01 0.016435869
Rdh12
Cyp26a1
Aldh1a1
Rdh8
Rdh11
Retsat
Cyp26b1
Rpe65
Dgat2
Aldh1a2
Dhrs3
a Gene names: Agrp, agouti related protein homolog (mouse); Brs3, bombesin-like
receptor 3; Cartpt, CART prepropeptide, Cckar, cholecystokinin A receptor; Cckabr,
cholecystokinin B receptor; Fyn, FYN oncogene related to SRC, FGR, YES; Galr2,
galanin receptor 2; Gcg, glucagon; Ghrl, ghrelin/obestatin; Ghsr, ghrelin/obestatin
prepropeptide; Hcrtr1, hypocretin (orexin) receptor 1; Mc4r, melanocortin 4
receptor; Pmch, pro-melanin-concentrating hormone; Pyy, peptide YY;
Ubr3, ubiquitin protein ligase E3 component n-recognin 3; Rdh12, retinol
dehydrogenase 12 (all-trans/9-cis/11-cis); Cyp26a1, cytochrome p450, family 26,
subfamily A, polypeptide 1; Aldh1a1, aldehyde dehydrogenase 1 family, member
A1; Rdh, retinol dehydrogenase 8 (all-trans); Rdh11, retinol dehydrogenase 11
(all-trans/9-cis/11-cis); Retsat, retinol saturase (all-trans-retinol 13, 14-reductase);
Cyp26b1, cytochrome p450, family 26, subfamily B, polypeptide 1; Rpe65,
retinal pigment epithelium-specific protein 65 kDa; Dgat2, diacylglycerol
O-acyltransferase 2; Aldh1a2, Aldehyde dehydrogenase 1 family, member
A2; Dhrs3, dehydrogenase/reductase (SDR family) member 3
Abbreviations: NES normalized enrichment score; NOM nominal; FDR false
discovery rate
Fig. 3 Effect of dietary bovine lactoferrin on % fecal fat (a) and
jejunal mRNA levels of Fatty acid transporter (Cd36/FAT) (b) taken
from male C57/BL6J mice after 13 weeks of experimental diet
feeding. Data is represented as mean values ± SEM (n = 8). Different
letters indicate significant differences, and significance is determined
at P < 0.05
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between high fat diet fed groups in the corticosterone acti-
vation associated gene, 11β-hydroxysteroid dehydrogenase
type 1 (Hsd11β1) (Additional file 3: Figure S1E-F). The
mRNA levels of glucocorticoid receptor (Gccr), associated
with lipid uptake, were not significantly altered between
groups (Additional file 3: Figure S1G). The SAT mRNA
levels of genes associated with insulin signaling, namely
insulin receptor (Insr) and glucose transporter 4 (Glut4)
were also not significantly altered between high fat diet
fed groups (data not shown).
In the EAT, Lep mRNA levels were not significantly al-
tered between high fat diet groups (LFD: 1.00 ± 0.35; HFD:
2.82 ± 0.70; HFD + Lac: 3.65 ± 0.88). There were no signifi-
cant differences between HFD + Lac and HFD groups in
mRNA levels of Cepba, Ppara or Lpl, however there was a
significant increase in the mRNA levels of Cpt1b in the
HFD + Lac fed mice compared to the HFD group
(Additional file 5: Figure S3A-D). Finally, no significant
differences were found between groups in the mRNA
levels of Pparg, Hsd11β1, Gccr (Additional file 5: Figure S3
E-G) or insulin related Insr and Glut4 (data not shown).
Discussion
The purpose of this study was to better understand the
impact that dietary lactoferrin has on weight gain in
comparison to dietary casein during a 13-week high fat
dietary challenge. By the end of the trial, the HFD + Lac
group showed no difference in bodyweight, weight gain,
SAT mass, EAT mass, or % fat mass when compared to
HFD fed mice. However, the lactoferrin fed mice did
have significantly reduced plasma leptin concentrations
that were not reflective of mRNA levels in either the
SAT or EAT indicating that an impact on secretion or
post-translational modification was responsible for this
decrease. As plasma corticosterone levels were also re-
duced in the HFD + Lac group compared to the HFD
fed group and leptin is linked with central control of the
hypothalamus-pituitary-adrenal production of cortico-
sterone, it is possible that the reduction in plasma leptin
resulted in the reduction in plasma corticosterone levels,
however, we found evidence that suggests that retinol
metabolism in the hypothalamus may have also contrib-
uted to these effects.
The discrepancies between the findings in previous tri-
als and the current one in relation to lactoferrin effects
on weight gain and fat mass are likely due to variations
in experimental method. For example, in the Shi et al.
trial, the supplementation of lactoferrin, during weight
loss and weight regain regimen may have facilitated
lactoferrin to affect weight and fat mass [5]. In the
Morishita et al. trial, which lasted 4 weeks, ICR mice
were given lactoferrin through gastric intubation with a
diet containing 10 % energy from fat. When the same
trial was conducted in Sprague–Dawley rats fed a high
Fig. 4 Effect of dietary bovine lactoferrin on plasma leptin (a),
corticosterone (b), and insulin (c) concentrations taken from male
C57/BL6J mice after 13 weeks of experimental diet feeding. Data is
represented as mean values ± SEM (n = 8). Different letters indicate
significant differences, and significance is determined at P < 0.05.
Abbreviations: SAT, subcutaneous adipose tissue; LFD, 10 % energy
fat diet with 20 % energy casein; HFD, 45 % energy fat diet with
20 % energy casein; HFD + Lac, 45 % energy fat diet with 20 %
energy lactoferrin
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fat diet, no beneficial change in visceral fat accumulation
occurred [6]. The Morishita et al. study supported re-
sults from Takeuchi et al. that showed dietary bovine
lactoferrin reduces plasma TAG and NEFA concentra-
tions in mice fed a chow diet, however, when mice were
fed a high fat diet, the benefits associated with lactofer-
rin were abolished [7]. Our results are in line with the
Takeuchi and Morishita et al. studies [6].
Initially, mice fed the HFD + Lac averted significant
weight gain compared to the LFD group until week 8,
whereas, those fed casein gained significantly more
weight than the LFD group by week 2. While previous
studies have shown that mice fed a high fat diet with
WPI and BSA have significantly reduced weight gain
resulting in significantly reduced bodyweight over 13–14
weeks, the current study suggests that lactoferrin has a
less potent effect on weight gain under similar condi-
tions [3, 4]. We speculate that increased uptake of diet-
ary fat in the small intestine may account for why initial
reductions in weight gain did not extend past week 5 in
the HFD + Lac group. This is based on the significant
reduction of % fecal fat and the moderate increase in
jejunal Cd36/FAT mRNA levels in the HFD + Lac group
compared to the HFD fed mice.
Previously, Petit et al. reported that the gastrointestinal
tract of adult mice fed a high fat diet for three weeks
adapted to high levels of oral lipid intake through two
gastrointestinal adaptations. The first of these, namely
increased intestinal cell proliferation and increased villi
height, led to an increase in absorptive area in the small
intestine [16]. Presumably, the fat-mediated increase of
intestinal absorptive area partially led to greater uptake
of dietary fat in the Petit et al. study. Therefore, it is in-
teresting that previous studies have shown that bovine
lactoferrin also increases absorptive area in the gastro-
intestinal tract. Blais et al. reported that dietary bovine
lactoferrin bound to lactoferrin receptors in the small in-
testine of adult mice leads to an increase in enterocyte
proliferation, villus height, and reduction of cell apop-
tosis [17]. These findings could explain why HFD + Lac
fed mice had reduced faecal fat content than HFD
control.
The second gastrointestinal adaptation in response to
high fat diet feeding is a fatty acid-induced increase in
the expression of genes associated with lipid uptake,
which included the long-chain fatty acid transporter
Cd36/FAT [16]. Greater expression of CD36/FAT is
thought to lead to greater efficiency in the uptake of
lipids from the gastrointestinal lumen. This is consistent
with the reduced fat excretion and the increase in
CD36/FAT gene expression in the HFD + Lac, which
only reached a trend towards significance from HFD.
Interestingly, Petit et al. also reported that increases in
intestinal Cd36/FAT expression leads to larger chylo-
micron size. Larger chylomicrons are hydrolysed faster
by LPL and release more TAG into the blood [16], find-
ings that are consistent with plasma TAG concentrations
found in the HFD + Lac group when compared to the
LFD group when the same significant differences be-
tween the HFD and LFD group were not present.
Despite similar weight gain to the HFD fed mice, HFD
+ Lac mice had significantly reduced circulating levels of
leptin. It has been shown that ingested lactoferrin re-
duces visceral adipose tissue differentiation: however,
this is only if lactoferrin is not digested by pepsin [6]. In
support of previous findings, we did not see any changes
in mRNA for genes associated with adipocyte differenti-
ation between the HFD and HFD + Lac groups, namely
Pparg and C/ebpa, nor were there differences between
the two groups in adipose tissue mass or fat percentage.
As reductions in fat mass could not explain the plasma
leptin differences between the high fat diet groups, we
examined SAT and EAT mRNA levels of Lep, the gene
associated with leptin production. We found no changes
between high fat diet groups in either adipose tissue
indicating that posttranslational modification or
Table 3 Plasma amino acid concentrations in mice fed a HFD
or HFD + Lac for 13 weeks were determined using Joel Na+
high performance cation exchange columnc
Amino acids HFD HFD + Lac
Mean SEM Mean SEM
Glu 89.40a 3.68 69.10b 3.38
Gly 135.00a 4.27 164.00b 8.38
His 103.00a 8.79 67.02b 2.35
Ile 205.00a 9.87 267.00b 25.10
Asp 7.58 0.96 8.54 1.42
Cys 1 + 2 23.80 1.70 20.40 0.51
Leu 78.80 3.89 72.60 7.68
Val 131.00 5.85 111.00 6.88
Arg 51.30 8.57 61.30 9.10
Ser 65.01 2.43 67.90 5.19
Pro 113.00 20.30 169.00 28.50
Tyr 43.10 4.41 39.50 1.88
Phe 36.60 1.88 36.60 2.15
Lys 113.00 4.00 118.00 7.31
Cysteic Acid 9.26 0.88 10.80 0.64
Thr 81.10 3.71 82.80 4.62
Ala 182.00 12.25 168.00 2.04
Met 28.06 2.31 23.10 1.09
c All data is represented as mean ± SEM (n = 7–8). Dissimilar superscript letters
represent significant differences (p < 0.05). Abbreviations: HFD 45 % energy
high fat diet with 20 % energy casein, HFD + Lac 45 % energy high fat diet
with 20 % energy bovine lactoferrin
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mechanisms surrounding secretion contributed to the
decrease of plasma leptin concentrations [18].
In search of the mechanisms underlying the presumed
change in leptin secretion, we analysed plasma concen-
trations of amino acids and found a significant reduction
of glutamate in the HFD + Lac mice. Glutamate is has
been shown to be a powerful stimulant of leptin release
in the absence of glucose or insulin [19]. Another signifi-
cantly reduced amino acid in the HFD + Lac group was
histidine. Histidine is a precursor of glutamate, there-
fore, it is interesting that both of these amino acids were
reduced in the plasma of the HFD + Lac fed mice [19].
We also found that glycine, another amino acid associ-
ated with leptin release, was significantly increased in
the HFD + Lac group compared to the HFD mice.
Glycine acts to stimulate secretion of basal levels of lep-
tin, however, glycine also prevents the ability of insulin
to stimulate leptin secretion [19]. It is not known why
these amino acid profiles were altered between the high
fat diet groups, when metabolic activity was not signifi-
cantly different. Further work is needed to identify the
potential mechanisms involved.
In addition to reduced plasma leptin levels, the HFD +
Lac group had significantly less plasma corticosterone
than the HFD group. Leptin is linked with central con-
trol of the release of corticosterone, however it is un-
likely that the reduction in leptin is responsible for the
decreased corticosterone concentrations through Crh
and V1a as neither were altered between groups in this
study [20, 21]. Based on gene-set analysis, we speculate
that the decrease in corticosterone occurred through the
hypothalamic retinol metabolism pathway, which in-
creased in the HFD + Lac group compared to the HFD
group. This pathway ultimately leads to the production
of retinol-based metabolites, such as 13-cis-retinoic acid
and all-trans-retinoic acid [22]. Vitamin-A deficient rats
have been shown to have HPA-axis hyperactivity in re-
sponse to restraint stress without altering hypothalamic
Crh [23]. However, retinoic acid also acts to increase
hypothalamic Crh and V1a pathways and subsequently
increases plasma corticosterone [22]. Thus, further work
is needed to better understand what role, if any, the in-
crease gene sets linked to retinol metabolism may have
had in corticosterone metabolism in this study.
It is important to note that the gene set linked to
feeding behaviour was down-regulated in the hypo-
thalamus of HFD + Lac fed mice compared to HFD
controls. The genes in that pathway included those
associated with melanocortin signalling, which is posi-
tively regulated by leptin [24]. Notably, the decrease
in the activity of this pathway was not reflected in
energy intake or energy expenditure, presumably be-
cause of changes in other signalling pathways asso-
ciated with energy balance, including retinoic acid
signalling pathway and those regulated by cortico-
sterone (see below).
What impact the reduction in plasma leptin and cortico-
sterone levels played in the final fat mass accumulation of
HFD+ Lac fed mice remains to be determined. Excess
amounts of glucocorticoids have been shown to increase
the distribution of central adipose mass by increasing lipo-
genesis via Gccr and stimulation of Lpl expression [25]. It is
noteworthy that mRNA levels of Lpl and Gccr were not
altered between high fat diet groups. This coupled with the
lower plasma corticosterone levels in the HFD+ Lac fed
mice with similar % fat mass to HFD controls suggests that
reduced corticosterone signalling had no impact on lipid
accumulation in the HFD+ Lac group [26, 27].
In contrast, it is thought that the direct effect of leptin
on lipid metabolism in vivo is minimal in comparison to
the impact it has indirectly on energy intake [28].
Leptin’s regulation of insulin secretion and glucose me-
tabolism are also thought to factor into lipid metabolism
indirectly, and while plasma insulin was significantly in-
creased in the HFD + Lac groups compared to the LFD,
there were no differences in plasma glucose between
HFD and HFD + Lac groups [28]. This indicates that the
reduced leptin in the HFD + Lac group did not have a
significant effect on lipid metabolism. Leptin increases
cellular lipid metabolism via sympathetic catecholamin-
ergic innervation of fat depots, which is specific to epi-
didymal adipose tissue and leads to reduced Pparg and
subsequently reduced adipogenesis [28]. However, EAT
Pparg was not altered between high fat diet groups in
this study. Collectively, the data suggest that the
decrease in plasma leptin and corticosterone had little
effect on adipose gene expression, which contrasts with
the hypothalamus.
Finally, it is interesting to note the significant differences
found between the HFD + Lac fed mice and the LFD fed
mice not found between the HFD and LFD groups, be-
cause this suggests that a combination of dietary bovine
lactoferrin and altered carbohydrate:fat ratio may have led
to similar weight gain effects seen in the HFD but through
different pathways. For example, leptin stimulates POMC
neurons located in the arcuate nucleus (ARC) of the hypo-
thalamus, which ultimately leads to decreased energy con-
sumption and increased energy expenditure [29, 30]. The
HFD + Lac group, which had significantly reduced plasma
leptin, also had significantly reduced mRNA levels of
hypothalamic Pomc compared to the LFD group. This is
consistent with the finding that the HFD + Lac group con-
sumed cumulatively more EI alongside a modest reduc-
tion in energy expenditure, as depicted by VO2 values,
compared to the LFD group. No such reduction in VO2
values was found in the HFD group compared to the LFD
fed mice. Potentially exasperating the effect of reduced cir-
culating leptin on hypothalamic Pomc expression in the
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HFD + Lac group, orally administered bovine lactoferrin,
once digested, has been shown to act as an opiod [31].
Opiods have been shown to reduce hypothalamic POMC
expression via the opiodergic system [31, 32]. Therefore,
HFD + Lac mice may have had similar fat mass and weight
gain compared to the HFD due to a reduction in plasma
leptin and subsequent reductions in hypothalamic POMC.
Further work is needed to better understand what impact
bovine lactoferrin as part of a diet high in fat reduced in
carbohydrate has on weight gain, as it may ultimately lead
to greater weight gain in the long term.
Further work is also needed to clarify why the HFD + Lac
group took 8 weeks to become significantly greater in
weight than the LFD group when it only took the HFD
group 2 weeks. The limitations of the current study were
that leptin and corticosterone plasma concentrations were
only measured at the end of the trial. Ideally, both of these
hormones should have been monitored throughout the
study to identify a specific time point when leptin and cor-
ticosterone became reduced and what impact those reduc-
tions may have had on the final weight gain and
bodyweight of mice fed a HFD+ Lac.
Conclusion
HFD + Lac fed mice gained similar amounts of weight
gain and % fat to the mice fed HFD, but had significantly
reduced plasma leptin possibly through reduced secretion,
which can be linked to altered plasma amino acid profiles.
The reduction in plasma leptin accompanied a decrease in
expression of a hypothalamus associated gene set linked
to feeding behaviour. Plasma corticosterone concentra-
tions were significantly reduced in HFD + Lac fed mice,
which could be associated with reduced expression of
hypothalamic expression of the gene set linked to retinoic
acid metabolism. Based on these results, lactoferrin in a
diet-induced model of obesity, does not reduce weight
gain or % fat mass better than casein over a prolonged
period of time in male C57BL/6 J mice during adolescence
to adulthood, however it may be useful as a means of fur-
ther exploration into corticosterone and leptin pathways
affecting hypothalamic gene expression without the con-
founding effects of body weight change.
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